About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Houston | 428 Studies

Clinical Trials MelanomaHouston

Melanoma Clinical Trials in Houston

Find 428 clinical trials for melanoma near Houston, Texas. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 428 trials

CompletedInterferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaRATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells.NCT00002882·Houston, Texas CompletedNuclear and Near-Infrared (NIR) Imaging in MelanomaObjectives: 1.NCT01295931·Houston, Texas RecruitingA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsThis is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity…NCT06270706·New Haven, Connecticut and 21 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTargeted Intervention for Melanoma PreventionIn this study, the researchers will conduct interviews with melanoma patients to describe the sun exposure and sun protection practices of patients and their children.NCT00394134·Houston, Texas

CompletedA Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsThis is an open-label, multicenter, multi-dose escalation and dose expansion study in subjects with selected advanced solid tumors (Part A) and advanced metastatic pancreatic…NCT04731467·Scottsdale, Arizona and 17 others

CompletedTrametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 MutationsThis phase II trial studies trametinib in treating patients with melanoma with v-Raf murine sarcoma viral oncogene homolog B (BRAF) non-V600 mutations that has spread to other…NCT02296112·Washington D.C., District of Columbia and 3 others

CompletedA Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerThe reason for this study is to see if the CD73 inhibitor LY3475070 alone or in combination with pembrolizumab is safe and effective in participants with advanced cancer.NCT04148937·Denver, Colorado and 11 others

RecruitingStudy of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsThis study will evaluate the safety, tolerability, and preliminary effectiveness of AMXT 1501 and DFMO when combined with standard treatments for advanced solid tumors.NCT07287917·Tucson, Arizona and 19 others

CompletedPET-CT in the Management of Patients With Stage III or IV Metastatic MelanomaThe goal of this clinical research study is to learn how often using a positron emission tomography-computed tomography (PET-CT) scan in addition to a standard computed tomography…NCT00828126·Houston, Texas

TerminatedA Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)The primary purpose of this study is to compare pembrolizumab/vibostolimab to pembrolizumab with respect to recurrence-free survival (RFS).NCT05665595·La Jolla, California and 204 others

TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsThe purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely…NCT05169437·Yuma, Arizona and 79 others

RecruitingA Study of BI 3810944 in Patients With Advanced CancerThis study is open to adults with advanced cancer (solid tumours) for whom previous treatment was not successful, or no treatment exists.NCT07224425·Louisville, Kentucky and 6 others

CompletedStudy of ILX651 in Patients With Inoperable Locally Advanced or Metastatic MelanomaThis is a Phase II, non-randomized, open label study of ILX651 in patients with inoperable locally advanced or metastatic melanoma.NCT00068211·Scottsdale, Arizona and 18 others

CompletedDose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsA first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients with advanced or metastatic solid…NCT05479812·Scottsdale, Arizona and 13 others

TerminatedAPX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic MelanomaYou are being asked to take part in this study because you have metastatic (cancer that has spread) melanoma.NCT02706353·Houston, Texas

RecruitingProject: Every Child for Younger Patients With CancerThis study gathers health information for the Project: Every Child for younger patients with cancer.NCT02402244·Birmingham, Alabama and 278 others

RecruitingWell-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicThe primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of…NCT04474301·Houston, Texas

CompletedOral STAT3 Inhibitor, TTI-101, in Patients With Advanced CancersMany patients have cancers that have increased activity of a protein called STAT3 that contributes critically to the development and growth of their cancer.NCT03195699·Houston, Texas and 1 other

TerminatedHD IL-2 + Ipilimumab in Patients With Metastatic MelanomaPhase IV, open-label, randomized, two-arm, multi-center study in patients with metastatic melanoma who are treatment naïve or have previously received a single non-immunologic…NCT01856023·Tucson, Arizona and 11 others

CompletedA Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesThis is a study to determine the maximum tolerated dose (MTD) for CDX-1140 (CD40 antibody), either alone or in combination with CDX-301 (FLT3L), pembrolizumab, or chemotherapy and…NCT03329950·Scottsdale, Arizona and 10 others

PreviousPage 15 of 22Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma